Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Discussing treatment burden

Pippa Powell, Ravijyot Saggu, Steve Jones, Marco Clari, Isabel Saraiva, Georgia Hardavella, Kjeld Hansen, Hilary Pinnock
Breathe 2021 17: 200284; DOI: 10.1183/20734735.0284-2020
Pippa Powell
1European Lung Foundation, Sheffield, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravijyot Saggu
2University College London Hospitals NHS Foundation Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Jones
1European Lung Foundation, Sheffield, UK
3EU IPFF, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Clari
4Action for Pulmonary Fibrosis (APF), Peterborough, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Saraiva
5Dept of Public Health and Pediatrics, University of Torino, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Hardavella
6Associaçă Portuguesa de Pessoas com DPOC e outras Doenças Respiratórias Crónicas (RESPIRA), Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kjeld Hansen
1European Lung Foundation, Sheffield, UK
79th Dept of Respiratory Medicine, Athens Chest Diseases Hospital Sotiria, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kjeld.hansen@europeanlung.org
Hilary Pinnock
8Dept of Technology, Kristiania University College, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 17 no. 1
DOI 
https://doi.org/10.1183/20734735.0284-2020

Published By 
European Respiratory Society
Print ISSN 
1810-6838
Online ISSN 
2073-4735
History 
  • Received December 1, 2020
  • Accepted January 13, 2021
  • Published online March 4, 2021.

Copyright & Usage 
Copyright ©ERS 2021 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Pippa Powell1,
  2. Ravijyot Saggu2,
  3. Steve Jones1,3,
  4. Marco Clari4,
  5. Isabel Saraiva5,
  6. Georgia Hardavella6,
  7. Kjeld Hansen1,7⇑ and
  8. Hilary Pinnock8
  1. 1European Lung Foundation, Sheffield, UK
  2. 2University College London Hospitals NHS Foundation Trust, London UK
  3. 3EU IPFF, Brussels, Belgium
  4. 4Action for Pulmonary Fibrosis (APF), Peterborough, UK
  5. 5Dept of Public Health and Pediatrics, University of Torino, Turin, Italy
  6. 6Associaçă Portuguesa de Pessoas com DPOC e outras Doenças Respiratórias Crónicas (RESPIRA), Lisbon, Portugal
  7. 79th Dept of Respiratory Medicine, Athens Chest Diseases Hospital Sotiria, Athens, Greece
  8. 8Dept of Technology, Kristiania University College, Oslo, Norway
  9. 9Usher Institute, University of Edinburgh, Edinburgh, UK
  1. E-mail: kjeld.hansen{at}europeanlung.org
View Full Text

Article usage

Article usage: March 2021 to April 2022

AbstractFullPdf
Mar 2021387895
Apr 20211487153
May 2021533753
Jun 2021430632
Jul 202129139
Aug 202159633
Sep 2021511221
Oct 2021105835
Nov 2021146332
Dec 202128126
Jan 2022617312
Feb 2022711313
Mar 202276131
Apr 2022103912

Altmetrics

PreviousNext
Back to top
Vol 17 Issue 1 Table of Contents
Breathe: 17 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Discussing treatment burden
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Discussing treatment burden
Pippa Powell, Ravijyot Saggu, Steve Jones, Marco Clari, Isabel Saraiva, Georgia Hardavella, Kjeld Hansen, Hilary Pinnock
Breathe Mar 2021, 17 (1) 200284; DOI: 10.1183/20734735.0284-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Discussing treatment burden
Pippa Powell, Ravijyot Saggu, Steve Jones, Marco Clari, Isabel Saraiva, Georgia Hardavella, Kjeld Hansen, Hilary Pinnock
Breathe Mar 2021, 17 (1) 200284; DOI: 10.1183/20734735.0284-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • What key factors about treatment burden should be discussed during a consultation when medications are being prescribed?
    • What are the barriers to discussions about treatment burden?
    • How to have a productive discussion about treatment burden
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Editorials

  • Infectious disease in respiratory medicine
  • The COVID-19 Surge in Indonesia
  • Targeted therapy in respiratory disease
Show more Editorials

Viewpoint

  • Self-management in chronic lung disease
  • Palivizumab immunoprophylaxis for infants with BPD
  • Use of macrolides as first-line empirical therapy of CAP in children
Show more Viewpoint

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2022 by the European Respiratory Society